Top Markets
Coin of the day
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Classificação em ações #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Preço da ação
$0.0001
Última sincronização: 2025-03-10
Valor de mercado
$3.53K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar GeneThera, Inc. (GTHR)

Categoria

Histórico de preços das ações de GeneThera, Inc. (GTHR)
Preço de fecho mais alto: $0.00 em 2025-03-01

Preço de fecho mais baixo: $0.08 em 2012-09-01
Histórico de preços das ações da GeneThera, Inc. de 2012 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2025 0.00%
2024 -98.33%
2023 -59.45%
2022 -72.05%
2021 171.98%
2020 509.15%
2019 -73.75%
2018 -28.73%
2017 63.11%
2016 -70.47%
2015 65.96%
2014 -29.35%
2013 -78.40%
2012 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.46%
KR